Overview
- Trump, according to multiple reports Friday, approved a plan to oust FDA chief Marty Makary, though he has not formally fired him.
- A senior official and several outlets cite complaints about Makary’s leadership, drug approval calls, and his handling of the abortion pill mifepristone.
- Makary clashed with Trump over flavored vaping products and, after pressure, the FDA cleared several fruit flavors earlier this week.
- Senior White House staffers are set to meet Friday evening with anti-abortion activists who have pushed for Makary’s removal over mifepristone policy.
- His potential exit would deepen leadership gaps across health agencies as the FDA manages post-2025 layoffs, high turnover, and vacant top posts.